Cited by 671Cancer Cells and MetastasisBreast Cancer Treatment StudiesImmune cells in cancer

Stromal cells in tumor microenvironment and breast cancer

Open access
Mao, Yan, Keller, Evan T., Garfield, David H., Shen, Kunwei, Wang, Jianhua·2013·Cancer and Metastasis Reviews

Abstract

Cancer is a systemic disease encompassing multiple components of both tumor cells themselves and host stromal cells. It is now clear that stromal cells in the tumor microenvironment play an important role in cancer development. Molecular events through which reactive stromal cells affect cancer cells can be defined so that biomarkers and therapeutic targets can be identified. Cancer-associated fibroblasts (CAFs) make up the bulk of cancer stroma and affect the tumor microenvironment such that they promote cancer initiation, angiogenesis, invasion, and metastasis. In breast cancer, CAFs not only promote tumor progression but also induce therapeutic resistance. Accordingly, targeting CAFs provides a novel way to control tumors with therapeutic resistance. This review summarizes the current understandings of tumor stroma in breast cancer with a particular emphasis on the role of CAFs and the therapeutic implications of CAFs. In addition, the effects of other stromal components such as endothelial cells, macrophages, and adipocytes in breast cancer are also discussed. Finally, we describe the biologic markers to categorize patients into a specific and confirmed subtype for personalized treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10555-012-9415-3

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • By studying genetic alterations in tumor cells, the events through which the stroma affects cancer cells can be elucidated.

    “For example, by studying the genetic alterations in the tumor cells, the events through which the stroma affects cancer cells can be elucidated [48].”

    From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [48]

    The Abstract says that the molecular events through which reactive stromal cells affect cancer cells can be defined. Section 2.5 discusses genetic changes within tumor cells, but does not say that studying those changes is how stromal effects can be elucidated. The cited paper therefore supports the outcome, not the proposed method. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mao, Y., Keller, E. T., Garfield, D. H., Shen, K., & Wang, J.
Affiliations
  • Ruijin Hospital (CN)
  • University of Michigan (US)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Shen, Kunwei
  • Wang, Jianhua
Venue
Cancer and Metastasis Reviews
Published
2012-11-01
Volume
32
Issue
1-2
Pages
303-315
ISSN
  • 0167-7659 (ISSN-L)
  • 1573-7233
OpenAlex
W2032972527
Cited by
671
References
144
Citations by year
2026: 16 · 2025: 35 · 2024: 53 · 2023: 46 · 2022: 52 · 2021: 77 · 2020: 63 · 2019: 59 · 2018: 50 · 2017: 66 · 2016: 57 · 2015: 44 · 2014: 33 · 2013: 19
FWCI
3.16
Type
journal article
Language
en
Open access
Locations
  • Cancer and Metastasis Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (P01CA093900)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
breast cancer, tumor microenvironment, cancer-associated fibroblasts, tumor stroma, treatment resistance, angiogenesis, metastasis, tumor invasion, tumor-associated macrophages, tumor endothelial cells, biomarkers, personalized treatment, CAF-targeted therapy
MeSH terms
Breast Neoplasms, Female, Fibroblasts, Humans, Neoplasm Staging, Prognosis, Stromal Cells, Drug Resistance, Neoplasm, Epigenesis, Genetic, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review